Danish pharmaceutical giant Novo Nordisk has filed a lawsuit against online telehealth company Hims & Hers, alleging the company has been illegally marketing unapproved copies of its Wegovy obesity treatments in violation of patent protections.
CNBC reports that Novo Nordisk announced Monday it is suing Hims & Hers Health, seeking a permanent injunction to stop the telehealth company from selling compounded versions of its weight loss drugs and demanding monetary damages for patent infringement. The lawsuit marks a major escalation in the battle between traditional pharmaceutical manufacturers and compounding pharmacies over access to popular…
Read the full article at BREITBART.COM
